|
Comment on: Surgical experience and identification of errors in laparoscopic cholecystectomy.
|
Br J Surg
38400806
|
0 |
9.6 |
2024 |
|
Are multidisciplinary team meetings remotely efficient?
|
Br J Surg
38198151
|
0 |
9.6 |
2024 |
|
Surgical Sabermetrics: A Scoping Review of Technology-Enhanced Assessment of Non-Technical Skills in the Operating Room.
|
Ann Surg
38258573
|
0 |
9 |
2024 |
|
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
|
J Cachexia Sarcopenia Muscle
38343065
|
0 |
8.9 |
2024 |
|
Multicentre validation of CT grey-level co-occurrence matrix features for overall survival in primary oesophageal adenocarcinoma.
|
Eur Radiol
38526750
|
0 |
5.9 |
2024 |
|
A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals.
|
Front Oncol
38482202
|
0 |
4.7 |
2024 |
|
Validation of the emergency surgery score (ESS) in a UK patient population and comparison with NELA scoring: a retrospective multicentre cohort study.
|
Ann R Coll Surg Engl
38478020
|
0 |
1.4 |
2024 |
|
A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium.
|
Nat Med
38114667
|
0 |
82.9 |
2023 |
|
Impact of malnutrition on early outcomes after cancer surgery: an international, multicentre, prospective cohort study.
|
Lancet Glob Health
36796981
|
5 |
34.3 |
2023 |
|
Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma.
|
Nat Commun
37454136
|
4 |
16.6 |
2023 |
|
Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries.
|
Br J Surg
37079880
|
6 |
9.6 |
2023 |
|
The prognostic impact of pre-treatment cachexia in resectional surgery for oesophagogastric cancer: a meta-analysis and meta-regression.
|
Br J Surg
37527401
|
0 |
9.6 |
2023 |
|
Treatment of anastomotic leak after oesophagectomy for oesophageal cancer: large, collaborative, observational TENTACLE cohort study.
|
Br J Surg
37196149
|
0 |
9.6 |
2023 |
|
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
|
J Cachexia Sarcopenia Muscle
37671529
|
3 |
8.9 |
2023 |
|
Skeletal muscle analysis of cancer patients reveals a potential role for carnosine in muscle wasting.
|
J Cachexia Sarcopenia Muscle
37199284
|
2 |
8.9 |
2023 |
|
The Impact of Acute Systemic Inflammation Secondary to Oesophagectomy and Anastomotic Leak on Computed Tomography Body Composition Analyses.
|
Cancers (Basel)
37174044
|
0 |
5.2 |
2023 |
|
Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue.
|
Eur J Surg Oncol
36732207
|
1 |
3.8 |
2023 |
|
Erratum to "Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue" [Eur J Surg Oncol 49 (5) (May 2023) 974-982].
|
Eur J Surg Oncol
37572559
|
0 |
3.8 |
2023 |
|
Cancer cachexia - adopting a systems wide approach.
|
Curr Opin Clin Nutr Metab Care
37265093
|
0 |
3.1 |
2023 |
|
Cognitive Load Management: An Invaluable Tool for Safe and Effective Surgical Training.
|
J Surg Educ
36669990
|
1 |
2.9 |
2023 |
|
Protocol for a scoping review on 'surgical sabermetrics:' technology-enhanced measurement of operative non-technical skills.
|
BMJ Open
36737091
|
1 |
2.9 |
2023 |
|
Longitudinal characterisation of cachexia in patients undergoing surgical resection for cancer.
|
Curr Opin Support Palliat Care
37389614
|
0 |
2.1 |
2023 |
|
Cannabinoids in the treatment of cancer anorexia and cachexia: Where have we been, where are we going?
|
Asia Pac J Oncol Nurs
38197037
|
1 |
1.8 |
2023 |
|
The transcriptional landscape of endogenous retroelements delineates esophageal adenocarcinoma subtypes.
|
NAR Cancer
37502711
|
0 |
0 |
2023 |
|
Severity of oEsophageal Anastomotic Leak in patients after oesophagectomy: the SEAL score.
|
Br J Surg
35759409
|
3 |
9.6 |
2022 |
|
Textbook outcome following oesophagectomy for cancer: international cohort study.
|
Br J Surg
35194634
|
0 |
9.6 |
2022 |
|
Rates of Anastomotic Complications and Their Management Following Esophagectomy: Results of the Oesophago-Gastric Anastomosis Audit (OGAA).
|
Ann Surg
33630459
|
9 |
9 |
2022 |
|
The Obesity Paradox in Cancer: Is Bigger Better?
|
J Cachexia Sarcopenia Muscle
35506563
|
7 |
8.9 |
2022 |
|
A systematic review examining the relationship between cytokines and cachexia in incurable cancer.
|
J Cachexia Sarcopenia Muscle
35080147
|
22 |
8.9 |
2022 |
|
Cancer cachexia: a nutritional or a systemic inflammatory syndrome?
|
Br J Cancer
35523879
|
16 |
8.8 |
2022 |
|
Advance care planning in primary care for patients with gastrointestinal cancer: feasibility randomised trial.
|
Br J Gen Pract
35760566
|
2 |
5.9 |
2022 |
|
The Emerging Role of Intelectin-1 in Cancer.
|
Front Oncol
35186726
|
2 |
4.7 |
2022 |
|
Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions.
|
Molecules
36080280
|
1 |
4.6 |
2022 |
|
Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers.
|
Curr Treat Options Oncol
36269458
|
4 |
4.3 |
2022 |
|
Optimising Outcomes in Non Small Cell Lung Cancer: Targeting Cancer Cachexia.
|
Front Biosci (Landmark Ed)
35468688
|
0 |
3.1 |
2022 |
|
Albumin versus balanced crystalloid for resuscitation in the treatment of sepsis: A protocol for a randomised controlled feasibility study, "ABC-Sepsis".
|
J Intensive Care Soc
36860553
|
2 |
0.01 |
2022 |
|
The Implementation of Minimally Invasive Surgery in the Treatment of Esophageal Cancer: A Step Toward Better Outcomes?
|
Oncol Ther
35945401
|
0 |
0 |
2022 |
|
Rearrangement processes and structural variations show evidence of selection in oesophageal adenocarcinomas.
|
Commun Biol
35396535
|
4 |
0 |
2022 |
|
Remote diagnosis of surgical-site infection using a mobile digital intervention: a randomised controlled trial in emergency surgery patients.
|
NPJ Digit Med
34795398
|
9 |
15.357 |
2021 |
|
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study.
|
Anaesthesia
34371522
|
15 |
12.893 |
2021 |
|
A randomized, feasibility trial of an exercise and nutrition-based rehabilitation programme (ENeRgy) in people with cancer.
|
J Cachexia Sarcopenia Muscle
34612012
|
11 |
12.063 |
2021 |
|
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score.
|
Br J Surg
34227657
|
10 |
11.122 |
2021 |
|
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study.
|
Br J Surg
33761533
|
248 |
11.122 |
2021 |
|
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
|
Anaesthesia
34428858
|
43 |
10.7 |
2021 |
|
Relationship between cytokines and symptoms in people with incurable cancer: A systematic review.
|
Crit Rev Oncol Hematol
33482344
|
3 |
6.625 |
2021 |
|
The Emerging Role of Interleukin 1β (IL-1β) in Cancer Cachexia.
|
Inflammation
33907915
|
13 |
4.657 |
2021 |
|
Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study.
|
Eur J Surg Oncol
33451919
|
6 |
4.037 |
2021 |
|
Implementation of the Versius robotic surgical system for colorectal cancer surgery: First clinical experience.
|
Colorectal Dis
33544433
|
6 |
3.917 |
2021 |
|
REVOLUTION (Routine EValuatiOn of people LivIng with caNcer)-Protocol for a prospective characterisation study of patients with incurable cancer.
|
PLoS One
34914733
|
1 |
3.752 |
2021 |
|
Author's Reply: Prehabilitation Before Major Abdominal Surgery.
|
World J Surg
33399881
|
1 |
3.282 |
2021 |
|
Terminal Schwann cells at the human neuromuscular junction.
|
Brain Commun
33977269
|
10 |
0 |
2021 |
|
Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
|
Gastroenterology
32032585
|
28 |
22.682 |
2020 |
|
Neuromuscular junctions are stable in patients with cancer cachexia.
|
J Clin Invest
31794435
|
21 |
14.808 |
2020 |
|
Adipose depot gene expression and intelectin-1 in the metabolic response to cancer and cachexia.
|
J Cachexia Sarcopenia Muscle
32232960
|
8 |
12.91 |
2020 |
|
Perioperative nutrition: Recommendations from the ESPEN expert group.
|
Clin Nutr
32362485
|
38 |
7.324 |
2020 |
|
Machine learning to predict early recurrence after oesophageal cancer surgery.
|
Br J Surg
31997313
|
14 |
6.939 |
2020 |
|
Endoscopic tumour morphology impacts survival in adenocarcinoma of the oesophagus.
|
Eur J Surg Oncol
32814680
|
0 |
4.424 |
2020 |
|
A Modified AUGIS Delphi Process to Establish Future Research Priorities in Benign Upper Gastrointestinal Surgery.
|
World J Surg
31788725
|
3 |
3.352 |
2020 |
|
aNMJ-morph: a simple macro for rapid analysis of neuromuscular junction morphology.
|
R Soc Open Sci
32431902
|
10 |
2.963 |
2020 |
|
Intragastric laparoscopy for oesophageal eroded mesh removal: An approach to avoid resection.
|
J Minim Access Surg
32978356
|
0 |
1.407 |
2020 |
|
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.
|
Nat Genet
30718927
|
80 |
27.605 |
2019 |
|
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
|
Gut
30852560
|
11 |
19.819 |
2019 |
|
Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.
|
Nat Commun
31308377
|
15 |
12.121 |
2019 |
|
A tale of two CT studies: the combined impact of multiple human body composition projects in cancer.
|
J Cachexia Sarcopenia Muscle
30920777
|
3 |
9.802 |
2019 |
|
Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients.
|
J Cachexia Sarcopenia Muscle
31307124
|
17 |
9.802 |
2019 |
|
Total energy expenditure in patients with colorectal cancer: associations with body composition, physical activity, and energy recommendations.
|
Am J Clin Nutr
31225583
|
6 |
6.766 |
2019 |
|
Plasma Metabolomics Identifies Lipid and Amino Acid Markers of Weight Loss in Patients with Upper Gastrointestinal Cancer.
|
Cancers (Basel)
31635032
|
12 |
6.126 |
2019 |
|
Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
|
Int J Cancer
31050820
|
9 |
5.145 |
2019 |
|
Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.
|
Sci Rep
30670740
|
1 |
3.998 |
2019 |
|
Novel molecular targets of muscle wasting in cancer patients.
|
Curr Opin Clin Nutr Metab Care
30946052
|
5 |
3.775 |
2019 |
|
Combined exercise and nutritional rehabilitation in outpatients with incurable cancer: a systematic review.
|
Support Care Cancer
30944994
|
19 |
2.635 |
2019 |
|
Can a smartphone-delivered tool facilitate the assessment of surgical site infection and result in earlier treatment? Tracking wound infection with smartphone technology (TWIST): protocol for a randomised controlled trial in emergency surgery patients.
|
BMJ Open
31585971
|
2 |
2.496 |
2019 |
|
Protocol for developing quality assurance measures to use in surgical trials: an example from the ROMIO study.
|
BMJ Open
30826769
|
8 |
2.496 |
2019 |
|
Laparoscopically assisted versus open oesophagectomy for patients with oesophageal cancer-the Randomised Oesophagectomy: Minimally Invasive or Open (ROMIO) study: protocol for a randomised controlled trial (RCT).
|
BMJ Open
31748296
|
11 |
2.496 |
2019 |
|
International Variation in Surgical Practices in Units Performing Oesophagectomy for Oesophageal Cancer: A Unit Survey from the Oesophago-Gastric Anastomosis Audit (OGAA).
|
World J Surg
31332491
|
9 |
2.234 |
2019 |
|
Prehabilitation Before Major Abdominal Surgery: A Systematic Review and Meta-analysis.
|
World J Surg
30788536
|
71 |
2.234 |
2019 |
|
Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers.
|
Biomed Rep
30906545
|
6 |
1.573 |
2019 |
|
Identification of Prognostic Phenotypes of Esophageal Adenocarcinoma in 2 Independent Cohorts.
|
Gastroenterology
30165050
|
28 |
19.233 |
2018 |
|
Validated screening tools for the assessment of cachexia, sarcopenia, and malnutrition: a systematic review.
|
Am J Clin Nutr
30541096
|
33 |
6.568 |
2018 |
|
Cross sectional imaging of truncal and quadriceps muscles relates to different functional outcomes in cancer.
|
Clin Nutr
30612853
|
4 |
6.36 |
2018 |
|
Long-term outcomes following surgical repair of giant paraoesophageal hiatus hernia.
|
Surg Endosc
30406385
|
4 |
3.149 |
2018 |
|
Systematic Review and Meta-Analysis of Epidural Analgesia Versus Different Analgesic Regimes Following Oesophagogastric Resection.
|
World J Surg
28741191
|
4 |
2.768 |
2018 |
|
Evaluation of plasma microRNA-122, high-mobility group box 1 and keratin-18 concentrations to stratify acute gallstone disease: a pilot observational cohort study in an emergency general surgery unit.
|
BMJ Open
29703854
|
2 |
2.376 |
2018 |
|
Proteomic identification of potential markers of myosteatosis in human urine.
|
Biomed Rep
29904612
|
0 |
1.938 |
2018 |
|
Urinary diagnostic proteomic markers for dynapenia in cancer patients.
|
Biomed Rep
29904611
|
1 |
1.938 |
2018 |
|
The relationship between muscle mass and function in cancer cachexia: smoke and mirrors?
|
Curr Opin Support Palliat Care
30138131
|
19 |
1.916 |
2018 |
|
A randomised, phase II, unblinded trial of an Exercise and Nutrition-based Rehabilitation programme (ENeRgy) versus standard care in patients with cancer: feasibility trial protocol.
|
Pilot Feasibility Stud
30607255
|
5 |
0 |
2018 |
|
A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.
|
Genome Res
28465312
|
11 |
10.101 |
2017 |
|
Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.
|
Br J Surg
28944954
|
45 |
5.433 |
2017 |
|
Contemporary thoughts on the management of Spigelian hernia.
|
Hernia
28097450
|
9 |
2.417 |
2017 |
|
The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
|
Future Oncol
28621564
|
6 |
2.369 |
2017 |
|
Patients unfit for neoadjuvant therapy may still undergo resection of locally advanced esophageal or esophagogastric junctional cancer with acceptable oncological results.
|
Int J Surg Oncol (N Y)
29177210
|
2 |
0 |
2017 |
|
Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
|
Nat Genet
27595477
|
167 |
27.959 |
2016 |
|
Ken Fearon.
|
Cell Metab
28034417
|
0 |
18.164 |
2016 |
|
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.
|
J Cachexia Sarcopenia Muscle
27897403
|
33 |
12.511 |
2016 |
|
The relationship between muscle protein content and CT-derived muscle radio-density in patients with upper GI cancer.
|
Clin Nutr
28041627
|
6 |
6.402 |
2016 |
|
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.
|
Sci Rep
27600491
|
10 |
4.259 |
2016 |
|
Proteomic identification of potential cancer markers in human urine using subtractive analysis.
|
Int J Oncol
26984763
|
9 |
3.079 |
2016 |
|
Emergency laparoscopic mesh repair of parahiatal hernia.
|
ANZ J Surg
27017940
|
3 |
1.605 |
2016 |
|
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma.
|
Nat Genet
26192915
|
142 |
27.959 |
2015 |
|
Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients.
|
J Cachexia Sarcopenia Muscle
26136412
|
40 |
9.697 |
2015 |
|
Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn-5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer.
|
Proteomics Clin Appl
25644331
|
5 |
3.814 |
2015 |
|
Acute paraesophageal hernia repair: short-term outcome comparisons with elective repair.
|
Surg Laparosc Endosc Percutan Tech
25222713
|
3 |
1.02 |
2015 |
|
Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy.
|
Support Care Cancer
24389826
|
26 |
2.698 |
2014 |
|
Absence of correlation between serum CRP levels and mitochondrial D-loop DNA mutations in gastro-oesophageal adenocarcinoma.
|
J Cancer Res Ther
24762507
|
0 |
0.791 |
2014 |
|
Transfusion-Dependent Anaemia: An Overlooked Complication of Paraoesophageal Hernias.
|
Int Sch Res Notices
27379280
|
3 |
0 |
2014 |
|
LSCluster, a large-scale sequence clustering and aligning software for use in partial identity mapping and splice-variant analysis.
|
J Proteomics
23587666
|
2 |
3.914 |
2013 |
|
The Human Urinary Proteome Fingerprint Database UPdb.
|
Int J Proteomics
24222850
|
5 |
0 |
2013 |
|
Suppression of skeletal muscle turnover in cancer cachexia: evidence from the transcriptome in sequential human muscle biopsies.
|
Clin Cancer Res
22452944
|
40 |
9.619 |
2012 |
|
P-selectin genotype is associated with the development of cancer cachexia.
|
EMBO Mol Med
22473907
|
19 |
9.249 |
2012 |
|
mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinoma.
|
Br J Cancer
22677901
|
7 |
6.176 |
2012 |
|
Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function.
|
Clin Nutr
22296872
|
39 |
4.548 |
2012 |
|
Physical activity monitoring: a responsive and meaningful patient-centered outcome for surgery, chemotherapy, or radiotherapy?
|
J Pain Symptom Manage
22269181
|
37 |
2.905 |
2012 |
|
Esophagogastric trauma in Scotland.
|
World J Surg
22526046
|
3 |
2.673 |
2012 |
|
Intramyocellular lipid droplets increase with progression of cachexia in cancer patients.
|
J Cachexia Sarcopenia Muscle
21766057
|
56 |
9.697 |
2011 |
|
A new clinical sign in ruptured ectopic pregnancy.
|
Lancet
22177516
|
0 |
7.133 |
2011 |
|
Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring.
|
Clin Nutr
21733604
|
19 |
4.548 |
2011 |
|
How close are we to finding noninvasive markers for upper GI tract cancer?
|
Future Oncol
21992724
|
0 |
2.131 |
2011 |
|
Vascular access using the superficial femoral vein.
|
J Vasc Access
20683831
|
2 |
1.048 |
2011 |
|
Cavitating mesenteric lymph node syndrome in association with coeliac disease and enteropathy associated T-cell lymphoma: a case report and review of the literature.
|
Case Rep Med
21253476
|
2 |
0 |
2011 |
|
Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia.
|
Genome Med
20193046
|
50 |
7.071 |
2010 |
|
Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer.
|
Br J Cancer
20104227
|
24 |
6.176 |
2010 |
|
Mass spectrometric detection of candidate protein biomarkers of cancer cachexia in human urine.
|
Int J Oncol
20198343
|
10 |
3.079 |
2010 |
|
Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer.
|
Support Care Cancer
20221887
|
21 |
2.698 |
2010 |
|
Frequency of the mitochondrial DNA 4977bp deletion in oesophageal mucosa during the progression of Barrett's oesophagus.
|
Eur J Cancer
19211242
|
10 |
6.029 |
2009 |
|
The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982-2003.
|
Eur J Surg Oncol
19879717
|
20 |
3.522 |
2009 |
|
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell lines.
|
Br J Cancer
18594538
|
15 |
6.176 |
2008 |
|
The dermcidin gene in cancer: role in cachexia, carcinogenesis and tumour cell survival.
|
Curr Opin Clin Nutr Metab Care
18403914
|
10 |
4.023 |
2008 |
|
Cachexia, survival and the acute phase response.
|
Curr Opin Support Palliat Care
19060563
|
37 |
2.045 |
2008 |
|
Basic surgical training in the era of the European Working Time Directive: what are the problems and solutions?
|
Scott Med J
19051659
|
4 |
0.51 |
2008 |
|
Is there a human homologue to the murine proteolysis-inducing factor?
|
Clin Cancer Res
17785548
|
13 |
9.619 |
2007 |
|
Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2alpha may signal skeletal muscle atrophy in weight-losing cancer patients.
|
Br J Cancer
18087277
|
25 |
6.176 |
2007 |
|
Pathophysiology of cancer cachexia: much more than host-tumour interaction?
|
Clin Nutr
17507116
|
54 |
4.548 |
2007 |
|
Paraileostomy recontouring by collagen sealant injection: a novel approach to one aspect of ileostomy morbidity. Report of a case.
|
Dis Colon Rectum
17876671
|
1 |
3.519 |
2007 |
|
Objective physical activity and self-reported quality of life in patients receiving palliative chemotherapy.
|
J Pain Symptom Manage
17360150
|
31 |
2.905 |
2007 |
|
Biomarkers for cancer cachexia: is there also a genetic component to cachexia?
|
Support Care Cancer
18071761
|
17 |
2.698 |
2007 |
|
The scientific rationale for optimizing nutritional support in cancer.
|
Eur J Gastroenterol Hepatol
17413286
|
6 |
1.968 |
2007 |
|
Secondary perineal hernia following open abdominoperineal excision of the rectum: report of a case and review of the literature.
|
Hernia
17503160
|
15 |
1.932 |
2007 |
|
Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience.
|
Int Semin Surg Oncol
17937823
|
0 |
0 |
2007 |
|
The molecular mechanisms of skeletal muscle wasting: implications for therapy.
|
Surgeon
17009546
|
12 |
2.558 |
2006 |
|
Red herring: a rare cause of small bowel obstruction.
|
Surgeon
16623168
|
3 |
2.558 |
2006 |
|
The tip of the iceberg: a giant pelvic atypical lipoma presenting as a sciatic hernia.
|
World J Surg Oncol
16790047
|
11 |
1.6 |
2006 |
|
Cancer cachexia and fatigue.
|
Clin Med (Lond)
16688969
|
42 |
1.423 |
2006 |
|
Ventilatory and intensive care requirements following oesophageal resection.
|
Ann R Coll Surg Engl
16834853
|
3 |
1.35 |
2006 |
|
Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia.
|
Cancer Cell
16286249
|
139 |
27.407 |
2005 |
